Will Watchman Prevail With FDA? Boston Scientific’s LAA Closure Trial Raises Questions, Controversy
Executive Summary
The PREVAIL study of Boston Scientific’s Watchman left atrial appendage (LAA) closure device was primarily positive, but will it be enough to win FDA approval for the device?
You may also be interested in...
HRS 2014 Roundup
The 2014 Heart Rhythm Society Scientific Sessions ended May 10 in San Francisco with a big study from Boston Scientific on the benefits of implantable cardioverter defibrillator remote monitoring, and data on a smartphone-enabled electrocardiogram and the use of a spinal stimulator for heart failure patients. Earlier in the meeting, data were reported on the success of pacemaker remote monitoring and other studies.
HRS Round-Up: Remote Pacemaker Monitoring Improves Survival
Results of a St.Jude-sponsored trial of remote pacemaker monitoring was the highlight of the first two days of new clinical trial data presented at the Heart Rhythm Society annual scientific sessions in San Francisco.
Two Approaches To Attacking Left-Atrial Appendage To Stop AFib
Studies in the Journal of the American College of Cardiology look at outcomes with St. Jude Medical's Amplatzer Cardiac Plug and SentreHeart’s Lariat suture-delivery device.